Array Biopharma (ARRY) Prices 18.4M Share Stock Offering for Proceeds of ~$115M
- Discover Financial Services (DFS) Announces CEO Resignation
- Timken (TKR) Appoints Tarak Mehta as New CEO
- Crude Inventory Increases 3.2 Million Barrels
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Many senior Amazon employees won't get cash raises this year - Fortune
Array BioPharma Announces Pricing of Public Offering of Common Stock
September 27, 2016 9:23 PM EDTBOULDER, Colo., Sept. 27, 2016 /PRNewswire/ --Â Array BioPharma Inc. (Nasdaq: ARRY) announced today the pricing of an underwritten public offering of 18,400,000 shares of its common stock at a public offering price of $6.25 per share. The gross proceeds from the sale of the shares, before underwriting discounts and commissions and offering expenses, are expected to be approximately $115 million. The offering is expected to close on or about October 3, 2016, subject to customary closing conditions. Array also granted the underwriters a 30-day option to purchase up to 2,760,000 additional shares of common... More
Array BioPharma Announces Proposed Public Offering of Common Stock
September 27, 2016 4:27 PM EDTBOULDER, Colo., Sept. 27, 2016 /PRNewswire/ --Â Array BioPharma (Nasdaq: ARRY) today announced that it has commenced an underwritten public offering of $100 million of shares of its common stock. Array BioPharma also intends to grant the underwriters a 30-day option to purchase up to an additional $15 million of shares of its common stock offered in the public offering. All of the shares in the offering are to be sold by Array... More